Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Sonus and Nycomed Amersham establish ultrasound contrast agreement

Oct. 1, 1999

Chiron licenses HCV patent rights to Abbott

Sep. 30, 1999

DuPont seeks European approval for ultrasound contrast agent

Sep. 16, 1999

BBI Biotech receives three SBIR grants

Sep. 16, 1999

Nexell begins NIH-funded study to develop tumor cell test

Sep. 15, 1999

Imaging agent NeoTect available in U.S. for lung cancer diagnosis

Sep. 8, 1999

Company Profile: Intracel

Sep. 8, 1999

Boston Life Sciences reviews progress for first half of 1999

Aug. 31, 1999

Diatide awarded patent covering somatostatin analogues for tumor diagnosis and therapy

Aug. 31, 1999

U of M research team studies new compounds for imaging prostate cancer

Aug. 30, 1999

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...